Geron (GERN) Operating Income (2010 - 2026)
Geron's (GERN) quarterly Operating Income came in at $158000.0 in Q1 2026, up 100.95% year-on-year from $78628.1 in Q1 2025, and up 100.62% quarter-over-quarter from -$25.5 million in Q4 2025.
Geron (GERN) Operating Income (2010 - 2026) Analysis & Trends
Geron has disclosed Operating Income across 17 years of filings, most recently posting $158000.0 for Q1 2026.
- Operating Income for Q1 2026 came in at $158000.0, up 100.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$51.7 million (up 61.49% YoY), and the FY2025 annual result was -$68.6 million, up 60.52% from the prior year.
- Operating Income came in at $158000.0 for Q1 2026 at Geron, up from -$25.5 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $158000.0 in Q1 2026 to a low of -$69.3 million in Q2 2024.
- The 5-year median for Operating Income is -$28.7 million (2022), against an average of -$33.8 million.
- Across the five-year window, Operating Income sank 85.7% in 2023 and soared 100.95% in 2026, its largest moves.
- Geron's Operating Income stood at -$42.0 million in 2022, then dropped by 29.41% to -$54.3 million in 2023, then surged by 63.07% to -$20.0 million in 2024, then declined by 27.38% to -$25.5 million in 2025, then jumped by 100.62% to $158000.0 in 2026.
- The last three Operating Income figures came in at $158000.0 (Q1 2026), -$25.5 million (Q4 2025), and -$13.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -65.83 Mn |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 158,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 158,000.00 |
| Dec 31, 2025 | -25.54 Mn |
| Sep 30, 2025 | -13.89 Mn |
| Jun 30, 2025 | -12.45 Mn |
| Mar 31, 2025 | -16.70 Mn |
| Dec 31, 2024 | -20.05 Mn |
| Sep 30, 2024 | -28.22 Mn |
| Jun 30, 2024 | -69.33 Mn |
| Mar 31, 2024 | -56.13 Mn |
| Dec 31, 2023 | -54.29 Mn |
| Sep 30, 2023 | -47.61 Mn |
| Jun 30, 2023 | -51.95 Mn |
| Mar 31, 2023 | -40.09 Mn |
| Dec 31, 2022 | -41.95 Mn |
| Sep 30, 2022 | -39.95 Mn |
| Jun 30, 2022 | -27.98 Mn |
| Mar 31, 2022 | -28.68 Mn |
| Dec 31, 2021 | -30.98 Mn |
| Sep 30, 2021 | -25.67 Mn |
| Jun 30, 2021 | -28.89 Mn |